The video argues that five names have unusually large upside over the next 12 to 18 months because each has a near-term catalyst and a business re-rating path: Palantir (PLTR), Tempus AI (TEM), Fluence Energy (FLNC), Lightwave Logic (LWLG), and Airel Technologies/AIRJ. The first half leans on recent operating results and valuation for PLTR and TEM, while the middle argues FLNC is mispriced despite a $5.6 billion backlog and LWLG could rerate on foundry/customer announcements. The last segment shifts to AIRJ as the highest-upside, highest-risk name, with the thesis that a transition from technology to first commercial revenue could trigger a major rerating. A sponsored Volition RX (VNRX) segment closes the video and is separate from the stock-pick thesis.
The speaker opens by saying he is breaking down five stocks with 100%+ upside potential over the next 12 to 18 months and will explain the catalysts and the exact math for each to double.
Palantir (PLTR) is presented as one of the speaker's most famous long-time picks and one of the clearest growth opportunities over the next 12 to 18 months because it sits between an organization's data and the decisions it needs to make.
Palantir's reported quarter was called the strongest in company history: revenue was $1.935 billion, up 93% year over year and 19% sequentially, with 93% described as the highest growth rate ever recorded.
Palantir US commercial revenue grew 149% to $764 million and US commercial bookings surged 153% to $2.132 billion, while the company closed 220 deals worth at least $1 million, including 70 deals over $10 million.
Palantir raised full-year guidance to roughly $8.15 billion, about 82% growth, and the speaker said 2027 revenue could reach about $12.5 billion at 50% growth or about $13 billion at 60% growth.
The Palantir bull case is that if the stock doubles alongside that growth, investors would still be paying the same multiple in 18 months on a business more than twice the size, while the company keeps generating cash.
Tempus AI (TEM) is framed as a former Nancy Pelosi favorite that solved the disconnect between clinical records and molecular data in cancer by sequencing tumors and linking them to patient records at scale.
Tempus just posted its first quarterly profit in company history: Q2 revenue was $382.5 million, up 22%; diagnostics revenue rose 20% to $289.3 million; data and apps rose 28% to $93.2 million; and gap net income was $5.6 million versus a $42.8 million loss a year earlier.
Tempus guided full-year revenue to $1.595 billion to $1.605 billion, roughly 25% growth, and expects full-year adjusted EBITDA around $65 million, which the speaker said is about $72 million better than 2025.
Tempus was said to be trading around $42 and change versus a 52-week high of $104.32, with a market cap of roughly $8 billion against 2026 guidance of $1.595 billion to $1.605 billion, or about 5 times sales for a profitable company growing 25%.
If Tempus can repeat 25% growth in 2027, revenue would be roughly $2 billion, and the speaker said another beat-and-raise could rerate the stock.
Fluence Energy (FLNC) was described as a long-term idea that could swing 5% to 12% on earnings because it reports tomorrow, but the larger thesis is that it builds grid-scale battery storage and software that help the grid store electricity like a warehouse.
In segment 2, the speaker said Fluence year-to-date order intake doubled to about $2 billion versus $1 billion a year ago, backlog hit a record $5.6 billion, and roughly 85% of the $3.2 billion to $3.6 billion revenue guide is already under contract.
Fluence reaffirmed full-year 2026 guidance of $3.2 billion to $3.6 billion in revenue, $40 million to $60 million in adjusted EBITDA, and about $180 million in annual recurring revenue; Q2 revenue was $464.9 million, up 7.7%, and adjusted EBITDA improved to $9.4 million from negative $30.4 million a year earlier.
The Fluence valuation argument is that the stock has been trading under 1x forward enterprise value to revenue, and a double would only take it to about 2x forward revenue, which the speaker says is merely standard industrial valuation rather than an aggressive premium.
Lightwave Logic (LWLG) was presented as a potential rerating story because four Fortune 500 companies are designing next-generation hardware around its electro-optic polymer, which the speaker says can change optical properties instantly instead of using slow, heat-generating silicon modulators.
Lightwave said it now has agreements with four major foundries including Silera and Global Foundaries, plus two unnamed, with wafer runs underway or scheduled and three more foundries under consideration; its Tower Semiconductor deal targets modulators above 110 GHz for 200G and 400G architectures.
The Tower angle matters because Tower disclosed $1.3 billion in contracted silicon photonics revenue for 2027 from top customers and tied that demand to AI infrastructure, which the speaker says could be a potential addressable market for Lightwave and trigger a rerating even from a fraction of it.
The speaker says any catalyst such as a new customer name or a new supply agreement could move Lightwave aggressively, potentially doubling or tripling the stock over the coming weeks, while management is targeting high-volume production beginning in 2027 and is negotiating a material supply and licensing agreement.
Airel Technologies (AIRJ) was called the most extreme and riskiest name on the list, with a market cap around $300 million to $400 million and a business that pulls drinking water out of thin air for AI/data-center use cases.
The AirJ thesis is that conventional water-from-air methods are energy hungry, while its material-based approach grabs moisture without chilling the air and releases it with low-grade or waste heat; it has two products, AirJule Prime at roughly 2,000 liters a day and AirJule Core at about 250 liters a day.
AirJ said that in the last six weeks it moved from building to deploying, including a July 21 exclusive commercial partnership with Kubota for multi-unit residential developments across Texas and California with first deployments planned for Q3 this year.
In segment 3, the speaker said on July 28 AirJule deployed an AirJule Core system at GV Vernova's newly opened Frontier Campus in New York, and that GV Vernova is funding half of it as a 50/50 joint venture partner.
The AirJ argument is that once Kubota's exclusive sales rights produce revenue, the company shifts from technology to product, which could take it from zero revenue to first commercial revenue and spark the kind of small-cap rerating that can be the highest and fastest.
The video closes with a sponsored Volition RX (VNRX) segment pitching a small epigenetics company built around nucleosome-based blood tests across sepsis, human cancer, veterinary cancer, and research tools, with peer-reviewed data and a global Japanese diagnostics partner already putting one test onto its own machines.